What’s the main difference between active and inactive MS? The main difference between active and inactive MS is the presence of clinical activity. Clinical activity refers to relapses of symptoms.

52%). Median time from randomization to first-line multiple myeloma treatment had not been reached in the daratumumab group vs. 50.2 months for the active monitoring group (HR = 0.46; 95% CI ...

A novel study determined that monitoring inactive chronic hepatitis B (HBV ... levels in patients with chronic HBV. For active HBV cases the researchers suggest treatment with entecavir, which ...

Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high-risk smoldering multiple myeloma ...